Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | $14.00 → $13.50 | Market Perform | BMO Capital Markets |
| 1/24/2023 | $13.00 → $11.00 | Overweight → Neutral | JP Morgan |
| 12/29/2021 | $17.00 → $13.50 | Buy | Needham |
| 10/5/2021 | $14.00 | Market Perform | BMO Capital |
| 9/13/2021 | $18.00 | Outperform | RBC Capital |
| 9/7/2021 | Outperform | William Blair | |
| 8/26/2021 | $17.00 | Overweight | JP Morgan |
BMO Capital Markets reiterated coverage of N-able with a rating of Market Perform and set a new price target of $13.50 from $14.00 previously
JP Morgan downgraded N-able from Overweight to Neutral and set a new price target of $11.00 from $13.00 previously
Needham reiterated coverage of N-able with a rating of Buy and set a new price target of $13.50 from $17.00 previously